المؤلفون: Ga, Tsaur, To, Riger, Am, Popov, Tv, Nasedkina, Am, Kustanovich, Ag, Solodovnikov, Ov, Streneva, Egor Shorikov, Sv, Tsvirenko, Li, Saveliev, Lg, Fechina

المصدر: Europe PubMed Central

مصطلحات موضوعية: Male, Neoplasm, Residual, Bone Marrow, Antineoplastic Combined Chemotherapy Protocols, Humans, Infant, Female, Histone-Lysine N-Methyltransferase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, Myeloid-Lymphoid Leukemia Protein

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0878cb61d5654a8c9a8e113b4caa3547
http://europepmc.org/abstract/med/26189286

المؤلفون: Tsaur GA, Riger TO, Popov AM, Nasedkina TV, Kustanovich AM, Solodovnikov AG, Streneva OV, Shorikov EV, Tsvirenko SV, Saveliev LI, Fechina LG

المصدر: Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2015 Apr; Vol. 60 (4), pp. 14-22.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Meditsina Country of Publication: Russia (Federation) NLM ID: 9432021 Publication Model: Print Cited Medium: Print ISSN: 0869-2084 (Print) Linking ISSN: 08692084 NLM ISO Abbreviation: Klin Lab Diagn Subsets: MEDLINE

مواضيع طبية MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Bone Marrow/*pathology , Histone-Lysine N-Methyltransferase/*genetics , Myeloid-Lymphoid Leukemia Protein/*genetics, Female ; Humans ; Infant ; Male ; Neoplasm, Residual ; Prognosis

المؤلفون: Karachunsky AI; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Rumyantseva YV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Lagoiko SN; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Bührer C; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Tallen G; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Aleinikova OV; Republican Research and Practical Center for Pediatric Oncology and Hematology, Minsk, Belarus., Bydanov OI; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; Republican Research and Practical Center for Pediatric Oncology and Hematology, Minsk, Belarus., Korepanova NV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Baidun LV; Russian Children's Clinical Hospital, Ministry of Health of Russia, Moscow, Russia., Nasedkina TV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Stackelberg AV; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Novichkova GA; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Maschan AA; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Litvinov DV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Ponomareva NI; Russian Children's Clinical Hospital, Ministry of Health of Russia, Moscow, Russia., Kondratchik KL; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia; Morozov City Children's Clinical Hospital, Moscow Healthcare Department, Moscow, Russia., Mansurova EG; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Fechina LG; Regional Children's Clinical Hospital One, Yekaterinburg, Russia., Streneva OV; Regional Children's Clinical Hospital One, Yekaterinburg, Russia., Yudina NB; Voronezh Regional Children's Clinical Hospital One, Voronezh, Russia., Sharapova GR; Nizhnevartovsk District Children's Clinical Hospital, Nizhnevartovsk, Khanty-Mansi Autonomic District-Yugra, Russia., Shamardina AV; Nizhny Novgorod Regional Children's Clinical Hospital, Nizhny Novgorod, Russia., Gerbek IE; Tomsk Regional Clinical Hospital, Tomsk, Russia., Shapochnik AP; Orenburg Regional Clinical Oncology Dispensary, Orenburg, Russia., Rumyantsev AG; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Henze G; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany.

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (7), pp. 41-50.

نوع المنشور: English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Dexamethasone/*therapeutic use , Methylprednisolone/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Distribution ; Age Factors ; Child ; Child, Preschool ; Female ; Glucocorticoids/therapeutic use ; Humans ; Incidence ; Infant ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Prospective Studies ; Republic of Belarus/epidemiology ; Russia/epidemiology ; Survival Rate/trends ; Treatment Outcome ; Young Adult

المؤلفون: Rumiantseva IuV, Karachunskiĭ AI, Aleĭnikova OV, Fechina LG, Shamardina AV, Litvinov DV, Ponomareva NI, Boĭchenko EG, Dudkin SA, Streneva OV, Kondratchik KL, Mansurova EG, Minkina LM, Lapotentova ES, Iniushkina EV, Iudina NB, Pavlova GP, Zhukovskaia EV, Khlebnikova OP, Lagoĭko SN, Basharova EV, Denisov RE, Zlobina VD, Banshchikova ES, Aslanian KS, Kondakova EV, Tselousova EV, Miakova NV, Turobova TV, Ryskal' OV, Chipsanova NF, Varfolomeeva SR, Rumiantsev AG

المصدر: Terapevticheskii arkhiv [Ter Arkh] 2010; Vol. 82 (7), pp. 11-9.

نوع المنشور: Clinical Trial; English Abstract; Journal Article; Multicenter Study

بيانات الدورية: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Age Factors ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Child ; Child, Preschool ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Infant ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/prevention & control ; Recurrence ; Russia